Fingerprint
Dive into the research topics of 'CML-413 Efficacy and Safety of Bosutinib Versus Imatinib in US Patients With Newly Diagnosed Chronic Myeloid Leukemia After 5-Years Follow-Up in the BFORE Trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically